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Ela®n is a serine proteinase inhibitor highly expressed
in psoriatic epidermal keratinocytes, but expressed
scarcely, if at all, in normal skin. In addition to the
proteinase inhibiting domain, ela®n contains multiple
transglutaminase substrate domains and has been
identi®ed as a constituent of the epidermal corni®ed
cell envelope. It also contains a signal peptide
sequence, and previous immunoelectron microscopy
studies detected ela®n in lamellar granules and also in
the intercellular spaces. It has not been explained,
however, how and when ela®n molecules stored in
the granules are cross-linked into the cell envelope.
In order to elucidate this issue, we performed pre-
embedding and postembedding immunoelectron
microscopy of ela®n and involucrin, another cell
envelope constituent, using psoriatic epidermis.
Postembedding double immunoelectron microscopy
revealed that ela®n was within the secretory (lamellar)
granules and released into the intercellular spaces
when the cell envelope was not formed. In the
cells with involucrin-positive cell envelope, ela®n
immunolabels were localized diffusely within the cells
and also along the cell envelope. Pre-embedding
immunoelectron microscopy of puri®ed cell envelope
from psoriatic scale samples detected involucrin and
ela®n colocalizing on the cytoplasmic side of the cell
envelope. These ®ndings strongly suggest that ela®n-
containing granules are disintegrated upon the initi-
ation of cell envelope formation, and that ela®n
is cross-linked on to the involucrin-positive cell
envelope from the inside of keratinocytes. It seems
that psoriatic keratinocytes utilize ela®n as a major
component of the cell envelope, consistent with the
previously proposed ``precursor availability hypo-
thesis''. Key words: anti-lease/immunoelectron microscopy/
involucrin/secretory vesicles. J Invest Dermatol 119:50±55,
2002
C
orni®ed cell envelope (CE) is a covalently cross-
linked layer of protein that replaces the plasma
membrane and is covalently attached to the extra-
cellular lipid envelopes in the differentiated keratino-
cytes (Ishida-Yamamoto and Iizuka, 1998; Nemes
and Steinert, 1999). CE provides the tissue with a protective barrier
against the environment and also prevents water loss from the body
surface. The importance of CE for physiologic functions of the
integument is re¯ected by the association of a severe form of
ichthyosis, lamellar ichthyosis with decreased activities of transglut-
aminases that cross-link CE-precursor molecules (Huber et al, 1995;
Parmentier et al, 1995; Russel et al, 1995). The composition of CE
varies considerably among different epithelia and various pathologic
conditions. Among many CE precursor proteins, involucrin is
ubiquitously synthesized by all strati®ed squamous epithelia and
cross-linked into CE at the early stage serving as a scaffold on to
which other proteins are cross-linked (Steinert and Marekov, 1999;
Steinert, 2000). By contrast, expression of ela®n, another CE
protein, is negligible, if any, in normal adult epidermis, but is high
in some pathologic conditions, including psoriatic epidermis and
wounded epidermis (Schalkwijk et al, 1993; Pfundt et al, 1996; van
Bergen et al, 1996).
Ela®n (elastase speci®c inhibitor, SKALP; skin-derived anti-
leukopeptidase) is a small serine proteinase inhibitor derived from
the precursor preproela®n (Saheki et al, 1992; Molhuizen et al,
1993; Nara et al, 1994). This precursor protein contains a signal
peptide, and the consensus transglutaminase motifs, in addition to
the proteinase inhibiting domain. (Pro)ela®n fragments and their
cross-linkage with other CE components have been detected from
the fractions of proteolytically digested CE (Steinert and Marekov,
1995). As the ela®n gene translation product has a signal peptide
sequence, it is stored within secretory granules and is later extruded
from the cells (Pfundt et al, 1996). All other known CE precursor
proteins do not have signal sequences and appear to be cross-linked
from the inside of the plasma membrane. It remains unknown how
and when a secretory protein (pro)ela®n, is incorporated into CE.
To address this question, we performed pre-embedding and
postembedding immunoelectron microscopy of ela®n together
with involucrin in psoriatic epidermis.
MATERIALS AND METHODS
Samples Biopsies from chronic skin lesions of six patients with
psoriasis vulgaris were taken after obtaining informed consent. Scales
were also collected by scraping the psoriatic plaques of six patients with a
scalpel.
Anti-ela®n antibody Anti-human ela®n rabbit serum was purchased
from Peptide Institute (Osaka, Japan). It does not cross-react with
endothelin-1 (human), atrial natriuretic peptide (human), corticotropin
releasing factor (CRF) (human), substance P, and neuropeptide Y
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(human). With enzyme immunoassay using b-D-galactosidase as a label,
IC50 was 0.4 pmol per ml.
Immunoblot analysis Human ela®n (0.2 mg; Ala-Gln-Glu-Pro-Val-
Lys-Gly-Pro-Val-Ser-Thr-Lys-Pro-Gly-Ser-Cys-Pro-Ile-Ile-Leu-Ile-Arg-
Cys-Ala-Met-Leu-Asn-Pro-Pro-Asn-Arg-Cys-Leu-Lys-Asp-Thr-Asp-Cys-
Pro-Gly-Ile-Lys-Lys-Cys-Cys-Glu-Gly-Ser-Cys-Gly-Met-Ala-Cys-Phe-
Val-Pro-Gln, MW 5999.1, Peptide Institute) was loaded on to a lane of
15% sodium dodecyl sulfate±polyacrylamide slab gels 1 mm thick and
subjected to electrophoresis as described by Laemmli (1970). As
molecular weight markers, ovalbumin (45,000), carbonic anhydrase
(30,000), trypsin inhibitor (20,100), lysozyme (14,300), and aprotinin
(6500) (Amersham, Buckinghamshire, U.K.) were also loaded. After
electrophoresis, gel slabs containing separated proteins were electro-
phoretically transferred to polyvinylidene di¯uoride membrane
(Immobilon-p, Nihon Millipore, Tokyo, Japan) in transfer buffer
containing 25 mM Tris and 192 mM glycine. Nonspeci®c binding sites
were blocked by immersing the membranes in 5% skim milk in Tris±
HCl buffered saline (TBS) pH 7.6 for 1 h at room temperature. After
rinsing in TBS, the membrane was incubated with anti-ela®n anti-
serum (in 5000 dilution in TBS) overnight at 4°C. After rinsing in
TBS, the membrane was incubated with horseradish peroxidase linked
F(ab¢)2 fragment against rabbit immunoglobulin from donkey
(Amersham; 1:5000 dilution in TBS). ECL plus Western blotting
detection system (Amersham) was used for immunodetection. The
experiments were performed in duplicate, with the same results.
Immuno¯uorescence Cryostat sections of psoriatic skin were
incubated with a mixture of rabbit anti-ela®n anti-serum (in 1:100
dilution) and anti-involucrin mouse monoclonal antibodies (SY5,
NeoMarkers, Fremont, CA; 1:100 dilution) for 30 min at 37°C. This
was followed by incubation with a mixture of ¯uorescein isothiocyanate-
conjugated swine anti-rabbit IgG antibodies (1:20 dilution; DAKO,
Glostrup, Denmark) and Texas Red-conjugated sheep anti-mouse
immunoglobulins (1:10 dilution; Amersham) for 30 min at 37°C. Nuclei
were stained with 4¢,6-diamidino-2-phenylindole dihydrochloride
(Nacalai Tesque, Kyoto, Japan). Fluorescence immunolabeling was
observed using an Olympus BX-FLA-1 system (Tokyo, Japan). Digital
images were captured using an electric-cooled CCD camera (SenSys,
Photometrics, Tucson, AZ). The camera and image processing were
controlled using IP Laboratory Spectrum software (Scanalytics, Fairfax,
VA).
Immunohistochemistry For immunohistochemistry, a standard
streptavidin±biotin method using diaminobenzidine as a substrate for
peroxidase was employed on formalin-®xed and paraf®n-embedded
sections of psoriatic skin with anti-ela®n antibody.
Immunoelectron microscopy For postembedding immunoelectron
microscopy, skin tissue samples were either un®xed or pre®xed in 1%
glutaraldehyde and 0.2% picric acid in phosphate-buffered saline (PBS)
for 3 h at 4°C, and washed in PBS. Unreacted aldehyde groups were
quenched by incubating with 100 mM glycine in PBS for 1 h. The
tissues were then cryoprotected in 15% glycerol±PBS, rapidly frozen in
liquid propane at ±190°C, subjected to cryosubstitution in methanol
±80°C and embedded in Lowicryl K11M (at ±60°C) or HM20 resin (at
±50°C) according to the manufacturer's protocol (Chemische Werke
Lowi, Waldkraiburg, Germany). Ultrathin sections were prepared,
collected on formvar-coated nickel grids, and immunostained as
described previously (Ishida-Yamamoto et al, 1996). As the primary
antibodies, anti-ela®n anti-serum and anti-involucrin mouse monoclonal
antibodies were used. As labels, 10 nm gold-conjugated goat anti-rabbit
IgG and 5 nm gold-conjugated goat anti-mouse IgG (Amersham, 1:10
dilution) were used. For contrast, the sections were stained with uranyl
acetate alone or with uranyl acetate and lead citrate.
For pre-embedding immunoelectron microscopy, psoriatic stratum
corneum samples were obtained by scraping the lesions with a scalpel.
The samples were minced with scissors, homogenized, and treated with
four 10 min cycles of boiling in fresh washes (10 ml) of 10 mM Tris±
HCl buffer, pH 7.4, containing 2% sodium dodecyl sulfate and 1%
b-mercaptoethanol under rigorous agitation. The insoluble remnants
composed of CE were spun down for 30 min at 22,000 g, resuspended
in 10 mM Tris±HCl buffer. The puri®ed CE were then rinsed twice in
large volumes of PBS and sequentially immunolabeled with anti-human
ela®n antibody, 5 nm gold-conjugated goat anti-rabbit IgG, anti-
involucrin antibody, and ®nally 10 nm gold-conjugated goat anti-mouse
IgG. The samples were ®xed with 1% osmium tetroxide, dehydrated in
ethanol, and embedded in Epon812 resin. For all immunohistochemistry,
negative controls included incubation in the presence of a secondary
antibody alone, and incubation with unrelated primary antibodies.
RESULTS
Ela®n was within secretory granules, but also along the
CE Speci®city of anti-ela®n antibody was con®rmed by
immunoblot experiments that showed a band of 6 kDa matched
to the size of human ela®n (Fig 1). In immunohistochemical
studies, all samples from typical psoriatic plaques showed essentially
the same result. As has been reported previously (Molhuizen et al,
1993; Schalkwijk et al, 1993; Pfundt et al, 1996), ela®n was highly
expressed in the psoriatic epidermis (Fig 2). Double immuno-
¯uorescent staining of cryostat sections of frozen samples
demonstrated that ela®n was expressed later than involucrin in
the differentiation process of keratinocytes (Fig 2a). In ela®n
staining of formalin-®xed paraf®n-embedded samples, which
showed better tissue preservation, polarity was detected within
each spinous cell. Namely, stronger staining was noted in the apical
half than in the basal half of the cells (Fig 2b). Cell-peripheral
staining was noted in the more differentiated cells.
Subcellular localization of ela®n was further analyzed by
immunoelectron microscopy. Using the postembedding method
with Lowicryl K11M resin-embedded samples of both un®xed and
pre®xed materials, ela®n labeling was detected in the perinuclear
Golgi apparatus (Fig 3a) and within the granules close to the apical
surface of the keratinocytes (Fig 3b), con®rming previous observ-
ations (Pfundt et al, 1996). As ultrastructures of lamellar granules
were not well preserved in these samples, another preparation,
®xation with 1% glutaraldehyde and embedding in Lowicryl HM20
resin, was performed that disclosed that ela®n-positive granules
were with laminated internal structures (Fig 3c). Although CE-
associated ela®n immunostaining was not detected in a previous
report (Pfundt et al 1996), considerable ela®n labels along the CE
Figure 1. Immunoblot shows speci®city of ela®n anti-serum. A
positive band of about 6 kDa is detected (arrow). Human ela®n (0.2 mg)
was loaded on 15% sodium dodecyl sulfate±polyacrylamide gels and
immunoblotted with anti-ela®n anti-serum. The sized of molecular
weight standards are shown on the left.
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were found as well as in the intercellular spaces in the Lowicryl
K11M samples (Fig 4). As CE-associated staining was poor in the
Lowicryl HM20 samples, we used K11M for the rest of this study.
It was also noted that in the cells with ela®n-positive CE,
considerable ela®n immunolabels were observed within the
cytoplasm, where most of the labels were not associated with
granular structures (Fig 4b).
Subcellular localization of ela®n and involucrin was compared by
double immunoelectron microscopy staining. The timing of CE
formation was also assessed. It was revealed that where involucrin
was not deposited along the plasma membrane, ela®n molecules
were within the secretory granules (Fig 5a). In contrast, in the cells
with CE, involucrin and ela®n labels were colocalized along the CE
and also within the cytoplasm (Fig 5b).
Ela®n and involucrin were colocalized on the cytoplasmic
side of puri®ed CE Although involucrin and ela®n labels were
colocalized very closely together along CE in postembedding
immunoelectron microscopy samples, it was not certain whether
these two proteins were on the same side of the CE or on the
opposite side of it. Pre-embedding immunoelectron microscopy of
puri®ed CE from psoriatic epidermal scale samples was then
performed to address this issue. In this method, the brushy
cytoplasmic side of CE could be easily distinguished from the
relatively smooth extracellular surface. It was clearly demonstrated
that involucrin and ela®n were colocalized on the cytoplasmic side
of the CE (Fig 6). From these observations, the process of ela®n
cross-linking into CE as schematically shown in Fig 7 was
proposed. In the psoriatic epidermis, ela®n-containing lamellar
granules derived from Golgi apparatus move to the apical side of
keratinocytes and el®n is released extracellularly before the
formation of CE. In the cells with CE, ela®n-containing
granules, which have not been secreted, are disintegrated and
some ela®n molecules are cross-linked into the cytoplasmic side of
the CE.
DISCUSSION
Steinert and Marekov (1995) were the ®rst to identify ela®n as a
component of CE. They performed proteolytic digestion of CE
Figure 3. Ela®n molecules in the Golgi apparatus and in the
secretory (lamellar) granules. (a) Golgi apparatus; (b, c) secretory
(lamellar) granules. Post-embedding immunoelectron microscopy of the
lower spinous layer. Lowicryl K11M samples (a,b) and Lowicryl HM20
sample (c). Laminated structures of lamellar granules are appreciated in
the latter. d, desmosome. N, nucleus. Scale bar: 100 nm.
Figure 2. Ela®n and involucrin were expressed in the psoriatic
epidermis. (a) Double immuno¯uorescent microscopy of ela®n and
involucrin. Involucrin (red) is expressed from the lower spinous cells,
whereas ela®n (green) is expressed from the upper spinous cells. Nuclei
are stained with 4¢,6-diamidino-2-phenylindole dihydrochloride (blue).
(b) Immunoperoxidase staining of ela®n. Cytoplasmic ela®n staining is
stronger in the apical half than in the basal half in the spinous cells. It is
associated with cell membrane in the cells just under the stratum
corneum. Scale bar: 50 mm.
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puri®ed from human foreskin epidermis. Following fractionation,
they detected various peptides that contained sequences cross-
linked by isodipeptide bonds. Ela®n sequences were detected
forming cross-bridges with loricrin. Differing from all other known
CE components, ela®n is a secretory protein and it has been left
unexplained how and when it is cross-linked into CE.
Immunoelectron microscopic demonstration of CE components
has been done for various molecules (Haftek et al, 1991; Steinert,
1995; Ishida-Yamamoto et al, 1996; Steinert and Marekov, 1999),
but not for ela®n. Previous postembedding immunoelectron
microscopy of ela®n in psoriatic epidermis ®xed with 2%
paraformaldehyde and embedded in Lowicryl HM20 resin detected
ela®n labels in the intercellular spaces of the stratum corneum, over
the lamellar granules, small vesicular structures, and Golgi appara-
tus, but not on CE (Pfundt et al, 1996). In this study, we detected
ela®n signals on CE using postembedding and pre-embedding
immunoelectron microscopy, con®rming the notion that ela®n is a
component of CE. In addition, it was demonstrated that ela®n-
containing granules are disintegrated during CE assembly and ela®n
is cross-linked to CE from the inside of cells.
Previous pre-embedding immunoelectron microscopy of puri-
®ed CE has shown epitopes of various CE components on the
cytoplasmic side (Haftek et al, 1991; Steinert, 1995; Steinert and
Marekov, 1999). These include loricrin, keratin, desmoplakin,
envoplakin, periplakin, involucrin, and SPR1. Two major
transglutaminases that cross-link various components to form CE
are transglutaminases 1 and 2. The bulk of former enzyme is bound
to the plasma membranes from the cytoplasmic side by its N- and
S-fatty acylated terminal part. The latter enzyme is a cytoplasmic
protein. When transglutaminases are activated various cytoplasmic
proteins are cross-linked to the cytoplasmic side of the plasma
membrane. Interestingly it has been shown that extracellular
ceramides secreted from lamellar granules are also covalently cross-
linked into involucrin, periplakin, and envoplakin of CE (Marekov
and Steinert, 1998). Attachment of long-chain w-hydroxy-
ceramides to involucrin by ester bond formation was mediated by
transglutaminase 1 (Nemes et al, 1999). Cross-linking of CE with
extracellular molecule has also been suggested for corneodesmosin,
another component of lamellar granules (Haftek et al, 1991).
Although the mechanisms for cross-linking of these molecules into
the extracellular side of CE remain to be determined, it seems that
CE formation processes progress on both intracellular and
extracellular sides. There is a possibility that some ela®n molecules
are cross-linked from the extracellular side and the epitopes were
lost or masked and undetectable in our pre-embedding immuno-
electron microscopy method.
Epitope masking can be problematic in the postembedding
method as well. We detected rich ela®n labeling on CE in Lowicryl
K11M-resin embedded samples, but not in Lowicryl HM20
samples, as has been noted in a previous study (Pfundt et al,
1996). Although no detailed comparative studies of antigen
preservation in these two resins for embedding biologic specimens
have been performed, polarity of the resins might be relevant;
Lowicryl K11M is polar, whereas HM20 is apolar. Polar resin
gives increased surface irregularity that correlates with increased
ability to detect antigen on the sections (Kellenberger et al, 1987).
Temperature used for tissue embedding might also be critical. It has
been suggested that embedding at lower temperature gives better
antigen preservation (Hobot, 1989). Specimens can be embedded at
lower temperatures in K11M resin (±60°C) than in HM20 resin
(±50°C). As far as structural preservation of lamellar granules is
concerned, the latter resin was far superior to the former. This
might be related to the extent of lipid extraction during tissue
preparation because the laminated structure of lamellar granules
represents a stack of lipid lamellae. In the study of extent of
membrane lipid extraction during tissue preparation, HM20 gave
much less extraction than a polar resin, Lowicryl K4M (Weibull
et al, 1983).
Figure 4. Ela®n molecules are detected along
the CE. (a) Large arrowheads denote ela®n-positive
granules that have migrated toward the cell
periphery in the upper spinous cell layer. Some
are accumulated at the apical side of the cells
(arrows) to be released extracellularly. Some labels
are also seen along the CE (small arrowheads) in the
upper cell. Note that the cell membrane (*) of the
lower cell without CE is undulated compared
with that of the upper cell with CE. (b) Ela®n
labels are detected along the CE (arrows) as well as
intracellular and extracellular (*) spaces in the
corni®ed layer. d, desmosome. Scale bar: 100 nm.
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In normal epidermis, secretion of contents of lamellar granule is
completed just before the corni®cation. Whereas in psoriatic
epidermis, corneocytes contain remnants of lamellar granules,
indicating incomplete secretion (Mottaz and Zelickson, 1975;
Ghadially et al, 1996). It has previously been shown that in psoriatic
epidermis, CE was formed precociously in the spinous cells (Ishida-
Yamamoto and Iizuka, 1995). Therefore, it seems that CE
formation occurs so rapidly that not all lamellar granules reach
the apical cell surface and release their contents. Increased
intracellular calcium is a common trigger for exocytosis of Golgi-
derived secretory granules in many cell types (Madison and
Howard, 1996; Madison et al, 1998), and also for protein cross-
linking by transglutaminases. It has been shown that intracellular
calcium levels are elevated in the terminal differentiation of
keratinocytes (Menon and Elias, 1991) and A23187, a calcium
ionophore, induces CE formation, which is accompanied with
membrane-associated transglutaminase 1 activation in normal
human keratinocytes (Takahashi et al 2000). Therefore, it seems
that upon the elevation of intracellular calcium, ela®n stored within
granules are released extracellularly, CE formation is initiated, and
ultimately secretory granules are unable to fuse with the plasma
Figure 6. Ela®n and involucrin are on the same side of CE. Pre-
embedding immunoelectron microscopy of involucrin (10 nm gold) and
ela®n (5 nm gold) in a puri®ed psoriatic CE sample. Involucrin and
ela®n labels are colocalized on the brushy cytoplasmic side of the CE.
Scale bar: 100 nm.
Figure 7. Diagram of ela®n granules and CE formation. H, ela®n;
r, involucrin.
Figure 5. Ela®n granules are seen in the cells without involucrin-
positive CE, but undetectable in the cells with CE. Post-embedding
double immunoelectron microscopy of involucrin (5 nm gold) and ela®n
(10 nm gold). (a) In the lower cell without involucrin-positive CE,
ela®n-containing granules (larger arrowheads) are grouped at the periphery
of the cells. In the more differentiated upper cell, some involucrin labels
are detected along the CE (small arrowheads). Note that the cell
membrane (*) of the lower cell without CE is undulated compared with
that of the upper cell with CE (arrow). d, desmosome. (b) In the cells
with more matured CE, both involucrin and ela®n labels are seen along
the CE, but some labels are also retained within the cytoplasm. Scale
bar: 100 nm.
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membrane and disintegrate (Fig 7). Ela®n molecules are then
dispersed into the cytoplasm and cross-linked on to the CE from
inside the cells. Our data also support the ``precursor availability
hypothesis'', whereby transglutaminases utilize various substrates
that are available at the time of CE assembly (Robinson et al, 1997).
Although ela®n is not usually detected in normal human epidermal
CE, it can be a major component in psoriatic epidermis where
ela®n expression is greatly increased. Further studies concerning
protease inhibitory activities of cross-linked ela®n will provide
more insights into the biologic roles of ela®n as a component of
CE.
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